Exosomes Market By Product (Instruments, Kits & Reagents, Services), By Workflow (Downstream Analysis, Isolation Methods), By Application (Infectious Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Cancer, and Others), By End-Users (Hospitals, Academic & Research Institutes, Diagnostic Centers, Pharmaceutical Companies, and Others), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI509923 | Publish Date: April 2024 | No. of Pages: 170

Exosomes Market Companies

  • Hologic Inc.
  • Bio-Techne Corp.
  • Danaher Corp.
  • Lonza
  • Fujifilm Holdings Corp.
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • RoosterBio Inc.
  • Miltenyi Biotec
  • Abcam plc.

Recent News:

  • In July 2022, Cells for Cells, a clinical-stage biotechnology company pioneering allogeneic stem cell and stem cell therapies for high-impact chronic diseases, announced groundbreaking clinical data in 6 months of follow-up for the first patient receiving an exosome-produced therapy for osteoarthritis.
  • In April 2022, Global Stem Cells Group (GSCG) announced a new product launch with novel freeze-dried exosome technology. Global Stem Cells Group's new product line includes innovative anti-aging products that can regenerate the body's cells and tissues.
  • In November 2021, Lonza, a global manufacturing partner for the pharmaceutical, biotechnology and nutritional industries, announced the acquisition of an exosome manufacturing facility in Lexington, Massachusetts (USA) from Codiak BioSciences, a clinical-stage biopharmaceutical company pioneering the development of therapeutic exosome manufacturing facilities.